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SUMMARY.-The activity of RNA polymerase has been determined in the
nuclear fraction ofnormal mouse ovaries,60-day-oldpreneoplasticintrasplenic
ovariangrafts, and ovarian tumours developed after7 months of ovarygrafting
into the spleen. In preneoplastic grafts, RNA polymerase activitycorresponds
to that of normal ovaries, while in ovarian tumours, the enzyme value was 2-3
times higher. Oestradiol injected for 10 days, acting as depressant of the host
pituitary gonadotrophic potency, decreased the enzyme level in the grafts,
whereas no change was observed in similarly treated tumours. These facts
indicate that hormonal mechanisms regulating the genetic nuclear expression
areoperatingonlyinthe2-month-oldpreneoplasticovariancell,while autonomy
from these regulating mechanisms is achieved by 7-month-old tumour cells.
OvARiAN tumours develop in castrate mice, after one ovary has been
transplanted into the spleen (Li and Gardner, 1947; Furth and Sobel, 1947).
Microscopic evidence of tumour nodules in a grafted ovary can be detected 4
months after the grafting (Guthrie, 1957). Hence, the 2-month-old graft can be
regarded as preneoplastic tissue. Oestradiol treatment acting as a pituitary
depressor (Nhyake, 1961)produced in this tissue a decrease in activephosphorylase
levels (Bruzzone and Braneatelli, 1962a), whereas no such effect was observed in
ovarian tumours (Bruzzone and BrancateHi, 1962b). Thus it can be concluded
that the ovarian tumour cell has, at the enzymic level, lost its dependence on the
pituitarygonadotrophic hormones. Consequently, it seemsappropriate to assume
thatgenetic nuclear material is not hormonallyregulated in the ovarian tumoural
cell as it occurs in the 60-day-old ovariangraft.
The expresion of the genetic information contained in the nuclear DNA,
seems to be accomplished by the synthesis of ribonucleic acid (Smellie, 1965).
It should be interesting, therefore, to examine the level of RNA polymerase, the
enzyme thatcatalyses the RNA synthesis in bacteria and animal tissues (Smenie,
1965). The present report deals with levels of RNA polymerase in preneoplastic
and'neoplastic ovarian tissue, and its response to the depression of the gonado-
trophicpotency ofthe hostpituitary, inducedby oestradiol.
MATERIAL AND METHODS
Animals and injections
Virgin female mice of the C57BL/6 strain (Simonsen Laboratories, Gilroy,
California) were used. The intrasplenic ovarian grafts in 2-month-old animals159 RNA POLYMERASE IN OVARIAN GRAFTS AND TUMOURS
were effected as previously described (Bruzzone, 1968). Some of the grafted
animals were killed 60 days after the operation, while others were kept alive until
the ovariangrafts were 7 months old, in order to allow thedevelopment ofprimary
ovarian tumours. Oestradiol in saline suspension was injected subcutaneously
at doses of 10 Itg., for 10 days before the animals were killed. The animals were
kiHed by cervical dislocation and only the well-developed 60-day-old grafts were
recovered by dissecting out the spleen parenchyma. Tumours measuring at
least 5 mm. were recovered out from the spleen parenchyma in the same way as
above. Ovaries from 5- to 6-month-old virgin mice were used as normal tissue.
For microscopic studies, 60-day-oldgrafts andprimary tumours with the surroun-
ding spleen from the oestradiol and non-oestradiol treated groups, were fixed in
10 per cent buffered formalin solution. Paraffin sections at 5 It were stained with
haematoxylin and eosin.
RNA polymerase assay
Not less than 400 mg. of the starting material was collected, for each enzymic
determination, in an ice-cold medium containing 0-im KCI, 0.004m MgC12, and
0-04m Tris-HCI buffer pH 7-8 (Gorski, 1964). The fresh tissue was then trans-
ferred to a dry vessel, and kept in the deep freezer for no more than 21 days.
The thawed tissue was disrupted in anall-glass Potter-Elvejhem homogenizer for
1 minute, in about 10 ml. ofthe above medium in the cold room. Thehomogenate
was centrifuged at 5' C. during 10 minutes at 700 X g. The supernatant was
decanted and discarded. The precipitate was resuspended in the same medium,
and the centrifugation was repeated twice in the same way as above. The final
pellet (crude nuclear fraction) was resuspended to a final concentration of I ml.
of the medium per 500 mg. of the original tissue, and kept over ice until used as
enzyme source. The incubation mixture wasessentiallythe one usedbyNakagawa
and White (1966), and contained the following in a total volume of 0-5 ml.:
I umole ofATP, I /tmole ofCTP, I Itmole ofUTP, I m/,tmoleof 3H-GTP (I #Ci),
5/tmolesphosphoenolpyruvic acid, 10 Itg. ofpyruvatekinase, 10,amoles ofMgC12,
6 /tmoles of 2-mereaptoethanol, 50/tmoles of Tris-HCI buffer pH 7-8 and 0.2 ml.
of the
" crude nuclear suspension ". A-n additional tube containing 5 Itg. of
RNase was added to each enzymic determination. The reaction was started by
adding the nuclear suspension, and the incubation was carried out at 370 C. for
10 minutes. The reaction was stopped by adding 3 ml. of 5 per cent perchloric
acid. The test tubes werecentrifugedin a clinicalcentrifuge, at roomtemperature,
and the precipitate was resuspended twice in the 5 per cent perchloric acid. The
final precipitate was extracted with I ml. of 5 per cent perchloric acid at 90' C.
during 15 minutes with occasional shaking-up, and centrifuged after chilling. Radioactivity was measured in 0.1 ml. aliquots of the supernatant fluid that was
added to 15 ml. of Bray's solution (Bray, 1960). Potassium hydroxide at 10
per cent was used to neutralize the solution. The counting was performed in a
Packard Tricarb Liquid Scintillation Spectrometer. A blank value corresponding
to a zero time incubation was subtrated from all the experimental results.
DNA determinations
DNA was estimated by the diphenylamine method ofDische, as described by Seibert (1940), using 0-1 ml. of the supernatant of the incubated tubes. Calf
thymus DNA dissolved in warm 5 per cent perchloric acid was used as standard.160 S. BRUZZONE
Chemical-3
3H-GTP (specific activity 1.1 Ci/mm) was purchased from Schwarz Bio-
Research Inc. ATP, UTP, CTP, phosphoenolpyruvic acid, pyruvate kinase,
DNA Type I and RNase were obtained from Sigma Chemical Co.
RESULTS
Micro8copic ob8ervations in the ovarian graft8 and tumours
The microscopic structure of the 60-day-old grafts was essentially as that
previously reported in a different mice substrain (Bruzzone, 1968). In evident
contrast to the great number of blood-filled and cystic follicles, corpora lutea
wererarely seen. It must bepointed outthat Fekete (1953) observedthe presence
of corpora lutea in every ovary of the normal C57 virgin mice that she studied.
The relative absence of corpora lutea in the ovarian grafts, must be due to the
extensive process of follicularregression, asreported by Guthrie's minute observa-
tio'ns (1957). A prominent fact observed in ovarian grafts is the hyperplastic
developm.ent of interstitial cells (Guthrie, 1957). Interstitial tissue in virgin
adult mice ovaries seems to be composed of compact cells with round-shaped
nucleus and fibroblast-like cells, as seen in Fig. 1. On the contrary, interstitial
cells in ovarian grafts resemble large lutein-like cells, with homogeneous granular
cytoplasm, while the nucleus contains well defined chromatin and prominent
nucleoli (Fig. 2).
Graft weight in oestradiol treated animals was reduced to the same extent as
that observed before (Bruzzone and Brancatelli, 1962a). A noticeable reduction
in the size and number ofblood-filled andcystic follicles was observed. However,
relative absence in the number of corpora lutea persisted as observed in the non-
oestradiol treated animals. A prominent change was evident in interstitial
cells after oestradiol treatment. The cytoplasm evidenced a certain degree of
vacuolization with the presence of a vesicular nucleus, while connective tissue was
proliferating around the interstitial cells (Fig. 3). These findings suggest that
regressive changes were induced in the interstitial cells as a result of oestradiol
action on the pituitarygonadotrophic potency ofthe host (Miyake, 1961).
Some mitotic activity was evidenced in thegranulosalayers ofthe well preser-
ved follicles of the grafts (Fig. 4). Mitotic figures of granulosa cells were also
detected in oestradiol treated grafts, as seen in Fig. 5. This fact seems to be
in evident contrast to the regressive changes of interstitial cells described above
(Fig. 3).
EXPLANATION OF PLATE
FIG. I.-Interstitial tissue cells ofadult virgin mouse ovary. x 480.
FIG. 2.-Hyperplastic interstitial cells of a 60-day-old ovarian graft. x 480.
FIG. 3.-Interstitial cells of an oestradiol treated 60-day-old ovarian graft. Vacuolized cyto- plasm with vesicular nuclei and proliferating connective tissue. x 480.
FIG. 4.-Granulosa cells of a well preserved follicle in a 60-day-oAd intrasplenic ovarian graft.
x 480.
FIG. 5.-Mitotic figures on the granulosa layer in a follicle of an oestradiol treated 60-day-old
intrasplenic graft. Compare with the regressive changes of interstitial cells in Fig. 3.
x 480.
FIG. 6.-Well preserved lutein-like cells of an oestradiol treated primary ovarian tumour.
x 480.BRITISH JOURNAL OF CANCER. Vol. XXV, No. 1.
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The primary ovarian tumours developed 7 months after an intrasplenic ovary
grafting, were predominantly formed by granulosa and lutein-like cells, which
resemble types I and IV tumours of Gardner's classification (1955). Oestradiol
injections to mice bearing these tumours did not induce any change in the cyto-
plasm or nucleus of the tumoral ceRs (Fig. 6). It must be emphasized that no
follicles were found in all examined slides of ovarian tumours.
Requirementsfor the RNA polymerase, assay
The omission ofCTP or UTP from the reaction mixture caused a considerable
decrease in the incorporation of tritiated nucleotide (Table I). The addition of
actinomycin D to the incubation mixture, diminished even more the radioactive
incorporation (Table 1). These results indicated that RNA polymerase activity
TABLEI.-The, Effect ofNucleotideOMi88ionandActinomycin D on the RNA
Polymerase, Activity of60-day-old Ovarian Grafts
Counts incorporated/min./mg. DNA
Complete Minus Minus Complete system plus 10
system CTP CTP and LrTP umoles actinomycin D
2045 335 290 86
waspresent in the
" crude nuclear fraction
" ofthe 60-day-oldgrafts, and that the
basic requirements were those expected in the enzyme catalysed reaction (Weiss
and Gladstone, 1959; Smellie, 1965).
RNA polymerase activity in ovarian grafts andprimary ovarian tumour8
In order to provide an adequate amount oftissue for eachenzymic determina-
tion, it was necessary for a large number ofidentical specimens to bepooled. As
can be inferred from Table II, the
" crude nuclear fraction
" from 140 normal
ovaries, 35 grafts, and 44 oestradiol-treated grafts was used in each RNA poly-
merase assay. When tumour tissue was used, four and five specimens from both
non-treated and oestradiol-treated mice respectively were used (Table II).
As shown in Table IL enzymic activity of the 60-day-old grafts was slightly lower than thatdisplayedby normal ovaries. In thegrafts recovered from oestra-
diol-treated mice, the RNA polymerase level decreased to less than half that of
non-treated mice (Table II). The fact that alarge number ofspecimens was used
in eachenzymic assay conveys aspecialsignificance to the observed differences.
Average RNA polymerase activity in primary ovarian tumours, reached more
than twice the level detected in normal ovaries, and three times that ofthe grafts (Table 11). Oestradiol treatment did not affect the high enzyme level oftumours
(Table 11).
The addition ofribonuclease caused marked inhibition in triphosphate nucleo-
side incorporation in all examined tissues (Table II). This phenomenon, which
was of the same magnitude in all experiments, indicates that most of the formed
product was sensitive to the nuclease, and that the activities which were being measured in the various tissues were of similar nature. Although endogenous ribonuclease cannot be ruled out as causing the differences observed in the radio-
activeincorporation, whengrafts and tumours arecompared, it seemsunlikelythat162 S. BRUZZONE
4Q lz.
o
(D
0
4-) 00 0 CD
P-4
10 1* 0
0 p P-4 to
--4 C. m4oa.m 0 m aq m
4a
00 00
M
4z 0 0
00 0 m
4a
ONO 0 0 0 0
C; 6 o "'t, eq -dq C)
4-1 0 0 WC)
Cl
(D
Q
10 cq 00
C) m -4
pq
0
Cs C3
0 bo 14.
0 0 'D
0 0 m
g
.-4
4--)
Id IS 4 4b
+5 CD
0 0
;a (D 4Z 4-D 16.4 C4-1
-4 .0 5 4
-+.. 0 0
4-Z -4 QU tko 0 (D
> 0 O.,.4
0 o 0
Cs > > > C3 P4 .!4 C3 0
0 0163 RNA POLYMERASE IN OVARIAN GRAFTS AND TUMOURS
it may cause the differences because the same percentage of the formed product
was sensitive to the exogenous ribonuclease (Table 11).
DISCUSSION
The intrasplenic ovarian graft appears to be a good model for studying bio-
chemical changes to be detected during the period when normal cells undergo a
transformation into neoplastic cells. During this preneoplastic stage, whilst
there is a hyperplastic growth of interstitial cells, a gradual depletion offollicular
structures is also noticed, and these two changes take place in the whole gland
(Guthrie, 1957). Thus when the biochemist uses thesegrafts, he is dealing with a
pool oftissues which are inthe samedevelopmentalstage,besidesbeingcomposed of
structures related only to the primitive gland. The dependence of the grafted
ovary on the host pituitary gonadotrophic hormone (Li and Gardner, 1949;
Miller and Pfeiffer, 1950; Gardner, 1953; Ely, 1959) allows the research worker
to study hormonal influences on the enzymic pattem of the graft. However, a
grafted ovary shows certain drawbacks which limits its use when biochemical
work is to be effected. The small amount of tissue provided by each graft, as
well as its reduction in size after oestradiol treatment, constitute the most
significant disadvantages (Table 11). The time consuming and tedious work in
orderto recovertheovariantissuefromthespleenisanotherunfavourablesituation.
It is something already proved that RNA polymerase levels can be modified
in a number oftissues after hormone treatment. In the rat prostate, an increased
enzymic activity has been reported after inoculation of testosterone (Hancock
et al., 1962). The same effect has been detected in the uterus ofthe ratfollowing
an oestradiolinjection (Gorski, 1964). VanDyke and Katzman (1968) described a
rapid increase in the RNA polymerase activity in the infantile rat ovary after a
gonadotrophininjection. From thesefindings and those ofmanyothers, it can be
inferred that RNA polymerase activity can be regarded as a good index of the
hormone effect at molecular level in the target cell.
In accordance with the high pituitary gonadotrophic activity detected in
grafted mice by Miller and Pfeiffer (I950), itwould seemreasonable to assumethat
this sustainedgonadotrophicstimulation onthegrowinggrafted ovarymayinvolve
a high RNA polymerase activity. It must be recalled that in growing tissue
such as the regenerating liver, higher levels of RNA polymerase have been
detected (Tsukada and Lieberman, 1965). However, as shown in Table 11, the
nucleotide radioactive incorporation in the 60-day-old graft was of the same
magnitude as that ofnormal ovaries, inspite ofthe fact that thegraftweighed five
times the weight of a normal gland. Thus, it might be tentatively assumed that
the transcription of the genetic nuclear material in the preneoplastic ovarian cell,
might somehow be restrained. In this connection, it is important to note that
Gelboin (1968) reported diminished RNApolymerase activity in the preneoplastic liver of rats that were being fed with careinogenetic azo-dyes. A similar pheno-
menon has beenreported by Sunderman and Esfahani (1968) after the carcinogen nickel carbonyl was injected to rats.
Thehighenzymicactivity inprimary ovarian tumours (Table11), indicates the
presence of a different condition for the transcription of the genetic nuclear
material. It might bethought that the genetic nuclear complex is fullyexposed fortranscription in theneoplastic cell (Bresnick andMosse', 1969). It is ofinterest164 S. BRUZZONE
to note that Furth et al. (1966) observed a two-fold increase ofRNApolymerase in
spontaneous bovine lymphosarcoma over that ofnormal lymph nodes.
Taking into account the fact that regressive alterations of the interstitial cells
were observed in oestradiol treated grafts (Fig. 3), it seems reasonable to admit
that the decreased activity of the RNA polymerase observed in such grafts may
correspond to that of the interstitial cells. This assumption would seem to be
supportedby the fact that when folliclestimulating hormone wasgiven to grafted
mice which had been treated with oestradiol, the activephosphorylase levels were
restored. This increase in active enzyme was coincident with the disappearance
of vesicular nuclei and vacuolized cytoplasm in the interstitial cells of the graft
(Bruzzone, unpublished).
The decreased activity of RNA polymerase in the 60-day-old graft after
oestradiol treatment (Table II), indicates that regulatory mechanisms for RNA
synthesis are operative in these preneoplastic tissues, ix. the genetic expression
is under hormonal control in the preneoplastic ovarian cell. On the other hand,
since enzyme activity was not altered in steroid treated ovarian tumours (Table
II), it must be admittedthat thegeneticexpression is nolonger under thepituitary
gonadotrophic hormone control in tumour cells.
A decreased oxygen consumption and diminished activity of 5 enzymes ofthe
electron transport system has been reported in the preneoplastic ovarian grafts
(Bruzzone, 1968). Oestradiol treatment did not improve either the decreased
oxygen uptake or the low cytochrome oxidase level of the grafts (Bruzzone,
unpublished). Comparing these results with those obtained in thepresent report,
it might be assumed that the decreased respiratory activity of the ovariangrafts
would seem to be an irreversible phenomenon and non-dependent upon hormonal
interaction on the genetic nuclear material.
The experiments were conducted at the Institute of Hormone Biology, Syntex Research Center, Palo Alto, California, U.S.A., while the author, was the
holder of a John Simon Guggenheim Memorial Foundation Fellowship. The
author wishes to thank Professor Tulio Pizzi, Chairman of the Departmento de
Medicina Experimental Area Norte, for helpful discussions. Thanks are due also
to Miss Lois Folstad ofthe Syntex Research Center, Palo Alto,-California, U.S.A.
for the microscopic slides.
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